14-64805062-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001355436.2(SPTB):c.177C>T(p.Thr59Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0483 in 1,614,128 control chromosomes in the GnomAD database, including 2,448 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.046 ( 231 hom., cov: 32)
Exomes 𝑓: 0.048 ( 2217 hom. )
Consequence
SPTB
NM_001355436.2 synonymous
NM_001355436.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.46
Publications
13 publications found
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
- hereditary spherocytosis type 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- elliptocytosis 3Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary elliptocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary spherocytosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 14-64805062-G-A is Benign according to our data. Variant chr14-64805062-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.46 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.171 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPTB | NM_001355436.2 | c.177C>T | p.Thr59Thr | synonymous_variant | Exon 3 of 36 | ENST00000644917.1 | NP_001342365.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SPTB | ENST00000644917.1 | c.177C>T | p.Thr59Thr | synonymous_variant | Exon 3 of 36 | NM_001355436.2 | ENSP00000495909.1 | |||
| SPTB | ENST00000389722.7 | c.177C>T | p.Thr59Thr | synonymous_variant | Exon 2 of 35 | 2 | ENSP00000374372.3 | |||
| SPTB | ENST00000389720.4 | c.177C>T | p.Thr59Thr | synonymous_variant | Exon 3 of 32 | 5 | ENSP00000374370.4 |
Frequencies
GnomAD3 genomes AF: 0.0465 AC: 7069AN: 152120Hom.: 230 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
7069
AN:
152120
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0528 AC: 13275AN: 251452 AF XY: 0.0534 show subpopulations
GnomAD2 exomes
AF:
AC:
13275
AN:
251452
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0485 AC: 70889AN: 1461890Hom.: 2217 Cov.: 34 AF XY: 0.0490 AC XY: 35648AN XY: 727244 show subpopulations
GnomAD4 exome
AF:
AC:
70889
AN:
1461890
Hom.:
Cov.:
34
AF XY:
AC XY:
35648
AN XY:
727244
show subpopulations
African (AFR)
AF:
AC:
1257
AN:
33480
American (AMR)
AF:
AC:
1082
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
1239
AN:
26136
East Asian (EAS)
AF:
AC:
6217
AN:
39700
South Asian (SAS)
AF:
AC:
4823
AN:
86258
European-Finnish (FIN)
AF:
AC:
1733
AN:
53420
Middle Eastern (MID)
AF:
AC:
308
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
51034
AN:
1112008
Other (OTH)
AF:
AC:
3196
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
3913
7825
11738
15650
19563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1954
3908
5862
7816
9770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0465 AC: 7075AN: 152238Hom.: 231 Cov.: 32 AF XY: 0.0464 AC XY: 3457AN XY: 74426 show subpopulations
GnomAD4 genome
AF:
AC:
7075
AN:
152238
Hom.:
Cov.:
32
AF XY:
AC XY:
3457
AN XY:
74426
show subpopulations
African (AFR)
AF:
AC:
1559
AN:
41554
American (AMR)
AF:
AC:
520
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
155
AN:
3472
East Asian (EAS)
AF:
AC:
933
AN:
5172
South Asian (SAS)
AF:
AC:
282
AN:
4802
European-Finnish (FIN)
AF:
AC:
347
AN:
10610
Middle Eastern (MID)
AF:
AC:
34
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3125
AN:
68014
Other (OTH)
AF:
AC:
105
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
341
682
1022
1363
1704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
314
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.